Phase II study of esorubicin (4 ′ deoxydoxorubicin) in anthracycline naive patients with ovarian cancer

Michael D. Green, James L. Speyer, James C. Wernz, Nicoletta Colombo, Uziel Beller, Franco M. Muggia, E. Mark Beckman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of esorubicin (4 ′ deoxydoxorubicin) in anthracycline naive patients with ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences